Pulmonx Corporation LUNG Other International — Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pulmonx Corporation in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pulmonx Corporation's other international — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pulmonx Corporation's other international — revenue?
- Pulmonx Corporation (LUNG) reported other international — revenue of $51K in Q1 2026.
- How has Pulmonx Corporation's other international — revenue changed year-over-year?
- Pulmonx Corporation's other international — revenue increased by 34.2% year-over-year, from $38K to $51K.
- What is the long-term trend for Pulmonx Corporation's other international — revenue?
- Over 4 years (2021 to 2025), Pulmonx Corporation's other international — revenue has grown at a 19.4% compound annual growth rate (CAGR), from $128K to $260K.
- What does other international — revenue mean?
- This metric represents the total revenue generated from sales of medical technology products in geographic regions outside of the company's primary domestic and major international markets. It reflects the company's ability to penetrate emerging or smaller-scale global territories and diversify its geographic revenue stream. Monitoring this figure helps investors assess the scalability of the company's commercial footprint in secondary global markets.